Search research articles
Contact Us
Filters
Showing results (81-90 of 101) with videos related to
Page
of 11
Sort By:
Progress in Clinical and Biological Research
|
January 1, 1992
Molecular approaches to purging of chronic myelogenous leukemia marrow in autologous transplantation
T Yuan, Y Q Zhou, C V Herst, et al.
Blood
|
May 15, 1992
Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia
A del Giglio, S O'Brien, R Ford, et al.
Blood
|
March 1, 1985
Regulatory factors specific for adult and embryonic globin genes may govern their expression in erythroleukemia cells
N P Anagnou, T Y Yuan, E Lim, et al.
The New England Journal of Medicine
|
September 9, 1993
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation
S Giralt, S Escudier, H Kantarjian, et al.
Progress in Clinical and Biological Research
|
January 1, 1982
The use of Protein-A in the treatment of malignancy: rationale and the NCI experience
G L Messerschmidt, C Bowles, J Parrillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1992
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor
H M Kantarjian, M Talpaz, D Kontoyiannis, et al.
Stem Cells (Dayton, Ohio)
|
September 30, 2000
Results of retroviral and adenoviral approaches to cancer gene therapy
L H Yin, S Q Fu, T Nanakorn, et al.
Cancer Research
|
June 5, 2001
The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines
X Y Peng, J H Won, T Rutherford, et al.
Blood
|
September 1, 1996
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
A H Sarris, R Luthra, V Papadimitracopoulou, et al.
Methods in Molecular Medicine
|
March 11, 2011
Methods for Chemoprotection and Chemosensitization : MDR-1 For Chemoprotection Using Retroviruses to Modify Hematopoietic Cells and Cytosine Deaminase for Chemosensitization Using Adenoviral Vectors to Modify Epithelian Neoplastic Cells
S Shrimdkandada, S Q Fu, L H Yin, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 101) with videos related to
Sort By:
Page
of 11
Progress in Clinical and Biological Research
|
January 1, 1992
Molecular approaches to purging of chronic myelogenous leukemia marrow in autologous transplantation
T Yuan, Y Q Zhou, C V Herst, et al.
Blood
|
May 15, 1992
Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia
A del Giglio, S O'Brien, R Ford, et al.
Blood
|
March 1, 1985
Regulatory factors specific for adult and embryonic globin genes may govern their expression in erythroleukemia cells
N P Anagnou, T Y Yuan, E Lim, et al.
The New England Journal of Medicine
|
September 9, 1993
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation
S Giralt, S Escudier, H Kantarjian, et al.
Progress in Clinical and Biological Research
|
January 1, 1982
The use of Protein-A in the treatment of malignancy: rationale and the NCI experience
G L Messerschmidt, C Bowles, J Parrillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1992
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor
H M Kantarjian, M Talpaz, D Kontoyiannis, et al.
Stem Cells (Dayton, Ohio)
|
September 30, 2000
Results of retroviral and adenoviral approaches to cancer gene therapy
L H Yin, S Q Fu, T Nanakorn, et al.
Cancer Research
|
June 5, 2001
The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines
X Y Peng, J H Won, T Rutherford, et al.
Blood
|
September 1, 1996
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
A H Sarris, R Luthra, V Papadimitracopoulou, et al.
Methods in Molecular Medicine
|
March 11, 2011
Methods for Chemoprotection and Chemosensitization : MDR-1 For Chemoprotection Using Retroviruses to Modify Hematopoietic Cells and Cytosine Deaminase for Chemosensitization Using Adenoviral Vectors to Modify Epithelian Neoplastic Cells
S Shrimdkandada, S Q Fu, L H Yin, et al.
Page
of 11